We are really trying to find the balance between the burden and ensuring that the products are safe. We are looking at four different projects to reduce the burden on industry. One of them looks to introduce a simple registration process for natural health products. The other one looks to streamline premarket requirements where postmarket oversight is more appropriate. Those two combined would take a premarket scheme that has a service standard of 60 days and requires a certain amount of information, to something that is less burdensome in terms of the amount of information and much more streamlined in how you get the approval so that you can get your product to market faster.
We're also looking to introduce flexible risk-based postmarket vigilance requirements for all NHPs. We were talking about ADRs earlier on. Right now, the requirements are quite rigid. They need yearly summaries. We're taking a more flexible approach looking into that to see if, when something happens and you let us know, we could monitor that way.
Then finally, we're looking to introduce more flexible labelling requirements. I think I heard earlier that sometimes they're small bottles and it's hard to see the labels. We're recognizing that, and we're looking at the digital space as to how we can improve labels, not only for the manufacturer but for the consumer at the other end.
